deferoxamine has been researched along with Crohn Disease in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Crohn Disease: A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greco, L | 1 |
| Marino, F | 1 |
| Gentile, A | 1 |
| Catalano, G | 1 |
| Angilletta, D | 1 |
| Emerit, J | 1 |
| Pelletier, S | 1 |
| Tosoni-Verlignue, D | 1 |
| Mollet, M | 1 |
1 trial available for deferoxamine and Crohn Disease
| Article | Year |
|---|---|
Phase II trial of copper zinc superoxide dismutase (CuZnSOD) in treatment of Crohn's disease.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Crohn Disease; Deferoxamine; Drug Therapy, Combin | 1989 |
1 other study available for deferoxamine and Crohn Disease
| Article | Year |
|---|---|
Yersinia enterocolitica ileocolitis in beta-thalassemic patients.
Topics: Adult; Appendectomy; beta-Thalassemia; Comorbidity; Crohn Disease; Deferoxamine; Female; Humans; Mal | 2006 |